Decreased Occipital Lobe Metabolism by FDG-PET/CT: An Anti-NMDA Receptor Encephalitis Biomarker

Overview

Journal Neurol Neuroimmunol Neuroinflamm

Specialty Neurology

Date 2017 Nov 22

PMID 29159205

Citations 45

Authors

John C Probasco

Lilja Solnes

Abhinav Nalluri

Jesse Cohen

Krystyna M Jones

Elcin Zan

Mehrbod S Javadi

Arun Venkatesan

Affiliations

Soon will be listed here.

Abstract

Objective: To compare brain metabolism patterns on fluorodeoxyglucose (FDG)-PET/CT in anti-NMDA receptor and other definite autoimmune encephalitis (AE) and to assess how these patterns differ between anti-NMDA receptor neurologic disability groups.

Methods: Retrospective review of clinical data and initial dedicated brain FDG-PET/CT studies for neurology inpatients with definite AE, per published consensus criteria, treated at a single academic medical center over a 10-year period. Z-score maps of FDG-PET/CT were made using 3-dimensional stereotactic surface projections in comparison to age group-matched controls. Brain region mean Z scores with magnitudes ≥2.00 were interpreted as significant. Comparisons were made between anti-NMDA receptor and other definite AE patients as well as among patients with anti-NMDA receptor based on modified Rankin Scale (mRS) scores at the time of FDG-PET/CT.

Results: The medial occipital lobes were markedly hypometabolic in 6 of 8 patients with anti-NMDA receptor encephalitis and as a group (Z = -4.02, interquartile range [IQR] 2.14) relative to those with definite AE (Z = -2.32, 1.46; = 0.004). Among patients with anti-NMDA receptor encephalitis, the lateral and medial occipital lobes were markedly hypometabolic for patients with mRS 4-5 (lateral occipital lobe Z = -3.69, IQR 1; medial occipital lobe Z = -4.08, 1) compared with those with mRS 0-3 (lateral occipital lobe Z = -0.83, 2; < 0.0005; medial occipital lobe Z = -1.07, 2; = 0.001).

Conclusions: Marked medial occipital lobe hypometabolism by dedicated brain FDG-PET/CT may serve as an early biomarker for discriminating anti-NMDA receptor encephalitis from other AE. Resolution of lateral and medial occipital hypometabolism may correlate with improved neurologic status in anti-NMDA receptor encephalitis.

Citing Articles

Anti-NMDAR Encephalitis developing neuroleptic malignant syndrome.

Dhaliwal A, Sharma S, Panda S Ind Psychiatry J. 2024; 33(Suppl 1):S295-S296.

PMID: 39534148 PMC: 11553587. DOI: 10.4103/ipj.ipj_52_24.

Case report: 18F-FDG PET-CT findings in Bickerstaff encephalitis before and after treatment.

Kerik-Rotenberg N, Cruz-Perez J, Diaz-Meneses I, Aguirre Enriquez A, Gonzalez Rios S, Cortes-Mancera E Front Nucl Med. 2024; 3:1235173.

PMID: 39355031 PMC: 11440965. DOI: 10.3389/fnume.2023.1235173.

Buckley M, Balaji Warner A, Brahmer J, Cappelli L, Sharfman W, Fuchs E Oncologist. 2024; 30(1).

PMID: 39066587 PMC: 11783331. DOI: 10.1093/oncolo/oyae186.

The clinical and predictive value of F-FDG PET/CT metabolic patterns in a clinical Chinese cohort with autoimmune encephalitis.

Dai Y, Zhu Z, Tang Y, Xiao L, Liu X, Zhang M CNS Neurosci Ther. 2024; 30(7):e14821.

PMID: 38948940 PMC: 11215490. DOI: 10.1111/cns.14821.

Functional neuroimaging in patients with catatonia: A systematic review.

Duque L, Ghafouri M, Nunez N, Ospina J, Philbrick K, Port J J Psychosom Res. 2024; 179:111640.

PMID: 38484496 PMC: 11006573. DOI: 10.1016/j.jpsychores.2024.111640.

References

Meyer M, Hubner K, Raja S, Hunter K, Paulsen W . Sequential positron emission tomographic evaluations of brain metabolism in acute herpes encephalitis. J Neuroimaging. 1994; 4(2):104-5. DOI: 10.1111/jon199442104. View

Titulaer M, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T . Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2):157-65. PMC: 3563251. DOI: 10.1016/S1474-4422(12)70310-1. View

Wegner F, Wilke F, Raab P, Tayeb S, Boeck A, Haense C . Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography. BMC Neurol. 2014; 14:136. PMC: 4076767. DOI: 10.1186/1471-2377-14-136. View

Hubele F, Bilger K, Kremer S, Imperiale A, Lioure B, Namer I . Sequential FDG PET and MRI findings in a case of human herpes virus 6 limbic encephalitis. Clin Nucl Med. 2012; 37(7):716-7. DOI: 10.1097/RLU.0b013e31824c5e2f. View

Leypoldt F, Buchert R, Kleiter I, Marienhagen J, Gelderblom M, Magnus T . Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry. 2012; 83(7):681-6. PMC: 3740122. DOI: 10.1136/jnnp-2011-301969. View

Fisher R, Patel N, Lai E, Schulz P . Two different 18F-FDG brain PET metabolic patterns in autoimmune limbic encephalitis. Clin Nucl Med. 2012; 37(9):e213-8. DOI: 10.1097/RLU.0b013e31824852c7. View

Wong K, Tolia B, Bohnen N . Chronic sequelae of herpes simplex encephalitis demonstrated on interictal F-18 FDG PET/CT. Clin Nucl Med. 2008; 33(6):443-4. DOI: 10.1097/RLU.0b013e318170d4e0. View

Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J . Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005; 58(4):594-604. PMC: 2245881. DOI: 10.1002/ana.20614. View

Hughes E, Peng X, Gleichman A, Lai M, Zhou L, Tsou R . Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010; 30(17):5866-75. PMC: 2868315. DOI: 10.1523/JNEUROSCI.0167-10.2010. View

10.

Probasco J, Benavides D, Ciarallo A, Sanin B, Wabulya A, Bergey G . Electroencephalographic and fluorodeoxyglucose-positron emission tomography correlates in anti-N-methyl-d-aspartate receptor autoimmune encephalitis. Epilepsy Behav Case Rep. 2015; 2:174-8. PMC: 4308031. DOI: 10.1016/j.ebcr.2014.09.005. View

11.

Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld M, Balice-Gordon R . Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2010; 10(1):63-74. PMC: 3158385. DOI: 10.1016/S1474-4422(10)70253-2. View

12.

Graus F, Dalmau J . Role of (18)F-FDG-PET imaging in the diagnosis of autoimmune encephalitis - Authors' reply. Lancet Neurol. 2016; 15(10):1010. DOI: 10.1016/S1474-4422(16)30130-2. View

13.

Baumgartner A, Rauer S, Mader I, Meyer P . Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol. 2013; 260(11):2744-53. DOI: 10.1007/s00415-013-7048-2. View

14.

Dalmau J, Tuzun E, Wu H, Masjuan J, Rossi J, Voloschin A . Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007; 61(1):25-36. PMC: 2430743. DOI: 10.1002/ana.21050. View

15.

Morbelli S, Djekidel M, Hesse S, Pagani M, Barthel H . Role of (18)F-FDG-PET imaging in the diagnosis of autoimmune encephalitis. Lancet Neurol. 2016; 15(10):1009-10. DOI: 10.1016/S1474-4422(16)30140-5. View

16.

Vollenweider F, Leenders K, Scharfetter C, Antonini A, Maguire P, Missimer J . Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol. 1997; 7(1):9-24. DOI: 10.1016/s0924-977x(96)00039-9. View

17.

Chen B, Wang Y, Geng Y, Huang Y, Guo S, Mao X . Marked improvement of anti-N-methyl-D-aspartate receptor encephalitis by large-dose methylprednisolone and plasmapheresis therapy combined with F-fluorodeoxyglucose positron emission tomography imaging: A case report. Exp Ther Med. 2014; 8(4):1167-1169. PMC: 4151669. DOI: 10.3892/etm.2014.1849. View

18.

Fulham M, Brunetti A, Aloj L, Raman R, Dwyer A, DI CHIRO G . Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids. J Neurosurg. 1995; 83(4):657-64. DOI: 10.3171/jns.1995.83.4.0657. View

19.

Lagarde S, Lepine A, Caietta E, Pelletier F, Boucraut J, Chabrol B . Cerebral (18)FluoroDeoxy-Glucose Positron Emission Tomography in paediatric anti N-methyl-D-aspartate receptor encephalitis: A case series. Brain Dev. 2015; 38(5):461-70. DOI: 10.1016/j.braindev.2015.10.013. View

20.

Landeau B, Desson J, Desgranges B, Baron J . Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage. 1998; 7(3):176-84. DOI: 10.1006/nimg.1997.0318. View